Northway Biotechpharma collaborates with a Swiss company on the fast-track manufacturing of a SARS-CoV-2-neutralizing antibody for the therapy of COVID-19
Vilnius, Lithuania, and Schlieren, Switzerland – August 11, 2020 – Northway Biotechpharma (Northway), a leading biopharmaceutical Contract Development and Manufacturing Organization (CDMO), and Swiss biotech company Memo Therapeutics AG (MTx), announce a new partnership to develop a fast-track manufacturing path for MTx’s therapeutic COVID-19 antibody candidate. MTx today announces a collaboration with Northway to establish … Skaityti toliau